Reproducibility of cold provocation in patients with Raynaud's phenomenon
- PMID: 3668980
Reproducibility of cold provocation in patients with Raynaud's phenomenon
Abstract
Twenty-five patients with Raynaud's phenomenon had serial cold challenges during a double blinded drug trial. The data were analyzed to determine the reproducibility of cold provocation in the induction of critical closure of the digital artery in patients with Raynaud's phenomenon. Finger systolic pressure (FSP) was measured after local digital cooling using a digital strain gauge placed around the distal phalanx. Nineteen of 25 patients completed the study. The prevalence of inducing a Raynaud's attack decreased with each successive cold challenge from 74% of patients at initial challenge to 42% at the 3rd challenge. A lower temperature was required to induce a Raynaud's attack at last challenge (10.6 +/- 0.6 degrees C) compared to the first cold challenge (13.2 +/- 1.0 degrees C). Our data demonstrate adaptation to a laboratory cold challenge through the winter months in patients with Raynaud's phenomenon and show it is an important factor in objectively assessing drug efficacy in the treatment of Raynaud's phenomenon.
Similar articles
-
Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.Int Angiol. 1986 Jan-Mar;5(1):39-44. Int Angiol. 1986. PMID: 3734514 Clinical Trial.
-
Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.J Rheumatol. 1996 Dec;23(12):2068-78. J Rheumatol. 1996. PMID: 8970043
-
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.J Rheumatol. 1992 Sep;19(9):1407-14. J Rheumatol. 1992. PMID: 1279170 Clinical Trial.
-
Serotonin and Raynaud's phenomenon.J Cardiovasc Pharmacol. 1985;7 Suppl 7:S95-8. J Cardiovasc Pharmacol. 1985. PMID: 2412070 Review.
-
Clinical and physiological studies of Raynaud's phenomenon.Dan Med Bull. 1991 Dec;38(6):458-68. Dan Med Bull. 1991. PMID: 1802635 Review. No abstract available.
Cited by
-
Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.Ann Rheum Dis. 1998 Feb;57(2):70-8. doi: 10.1136/ard.57.2.70. Ann Rheum Dis. 1998. PMID: 9613334 Free PMC article. Review. No abstract available.
-
Vasodilators for primary Raynaud's phenomenon.Cochrane Database Syst Rev. 2021 May 17;5(5):CD006687. doi: 10.1002/14651858.CD006687.pub4. Cochrane Database Syst Rev. 2021. PMID: 33998674 Free PMC article.
-
Calcium channel blockers for primary Raynaud's phenomenon.Cochrane Database Syst Rev. 2016 Feb 25;2(2):CD002069. doi: 10.1002/14651858.CD002069.pub5. Cochrane Database Syst Rev. 2016. PMID: 26914257 Free PMC article.
-
Oral vasodilators for primary Raynaud's phenomenon.Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD006687. doi: 10.1002/14651858.CD006687.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2021 May 17;5:CD006687. doi: 10.1002/14651858.CD006687.pub4. PMID: 22786498 Free PMC article. Updated.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical